Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Americas

      Takeda and Orexigen Announce FDA Approval of Contrave ® (naltrexone HCI and bupropion HCI) Extended – release Tablets for Chronic Weight Management

      Americas
      Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration (FDA) has approved Contrave® (naltrexone HCI...

      New Pharmaceutical Solid Dosage Form Development Collaboration from Mettler Toledo

      Americas
      Mettler Toledo has initiated a collaboration with Actera Pharmaceuticals, San Francisco, to expand the applications of Focused Beam Reflectance Measurement (FBRM) probes into pharmaceutical...

      US Pharma now developing 44 drugs/vaccines for HIV/AIDS

      Americas
      The USA’s biopharmaceutical research companies are currently developing 44 medicines and vaccines for HIV/AIDS treatment and prevention, according to the latest Medicines in Development...

      Mylan to Acquire U.S. Rights to Arixtra® (fondaparinux sodium) Injection from Aspen

      Americas
      Mylan Inc. today announced that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S. commercialization, marketing and intellectual property...

      FDA Advisory Committee recommends against approval of Actavis’ Nebivolol/Valsartan Fixed-Dose combination NDA for Treatment of Hypertension

      Americas
      Actavis plc today confirmed that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted to recommend against...

      Baxter Announces Baxalta as the Name of the New Global Biopharmaceutical Company

      Americas
      Baxter International Inc. announced today that Baxalta Incorporated will be the name of the new, publicly traded biopharmaceutical company that is expected to launch...

      Spectrum Pharmaceuticals to Advance Neutropenia Drug

      Americas
      Spectrum Pharmaceuticals ( SPPI ) announced its intention to initiate a phase III study on SPI-2012 next year. SPI-2012, Spectrum Pharma's long acting granulocyte...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.